Evidence map›Paper›PMID 27511017›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.

Shi Di, Christy A Itoga, Marc O Fisher, Jonathan Solomonow, Emily A Roltsch, Nicholas W Gilpin, Jeffrey G Tasker

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Identification of a stress-responsive subregion of the basolateral amygdala in male rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Medial prefrontal cortex input to basolateral amygdala controls acute stress-induced short-term anxiety-like behavior in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  13. The Endocannabinoid System and Physical Exercise.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  16. Multiplexed Membrane Signaling by Glucocorticoids.Current opinion in endocrine and metabolic research · 2022
    Article
  17. Article
  18. The glucocorticoid footprint on the memory engram.Current opinion in endocrine and metabolic research · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shi DiDepartment of Cell and Molecular Biology and tasker@tulane.edu sdi@tulane.edu.
Christy A ItogaDepartment of Physiology, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana 70112.ORCID 0000-0002-6740-5577
Marc O FisherNeuroscience Program, Tulane University, New Orleans, Louisiana 70118, and.ORCID 0000-0003-2519-1686
Jonathan SolomonowNeuroscience Program, Tulane University, New Orleans, Louisiana 70118, and.ORCID 0000-0001-5842-4189
Emily A RoltschDepartment of Physiology, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana 70112.
Nicholas W GilpinDepartment of Physiology, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana 70112.
Jeffrey G TaskerDepartment of Cell and Molecular Biology and Neuroscience Program, Tulane University, New Orleans, Louisiana 70118, and tasker@tulane.edu sdi@tulane.edu.ORCID 0000-0003-1977-4199
Louisiana State University Health Sciences Center New Orleans · USInstitute of Molecular and Cell Biology · RUTulane University · US

Funding

Role of Neuropeptides in Stress-Induced Escalation of Alcohol DrinkingR01AA023305 · NIAAA · LSU HEALTH SCIENCES CENTER · PI GILPIN, NICHOLAS WARREN · 2014 to 2024
$3.7M
Stress Facilitation of Fear Memory: Cellular MechanismsR01MH104373 · NIMH · TULANE UNIVERSITY OF LOUISIANA · PI TASKER, JEFFREY G · 2015 to 2019
$1.9M
Post-Traumatic Stress Disorder and Alcohol DependenceR00AA018400 · NIAAA · LSU HEALTH SCIENCES CENTER · PI GILPIN, NICHOLAS WARREN · 2011 to 2013
$705k
Glucocorticoid-endocannabinoid interactions in the amygdalaR21MH090453 · NIMH · TULANE UNIVERSITY OF LOUISIANA · PI TASKER, JEFFREY G · 2010 to 2011
$408k
NIAAA NIH HHS R00 AA018400NIAAA NIH HHS R01 AA023305NIMH NIH HHS R01 MH104373NIMH NIH HHS R21 MH090453
6 · The paper itself

Abstract

unlabelledStress and glucocorticoids stimulate the rapid mobilization of endocannabinoids in the basolateral amygdala (BLA). Cannabinoid receptors in the BLA contribute to anxiogenesis and fear-memory formation. We tested for rapid glucocorticoid-induced endocannabinoid regulation of synaptic inhibition in the rat BLA. Glucocorticoid application to amygdala slices elicited a rapid, nonreversible suppression of spontaneous, but not evoked, GABAergic synaptic currents in BLA principal neurons; the effect was also seen with a membrane-impermeant glucocorticoid, but not with intracellular glucocorticoid application, implicating a membrane-associated glucocorticoid receptor. The glucocorticoid suppression of GABA currents was not blocked by antagonists of nuclear corticosteroid receptors, or by inhibitors of gene transcription or protein synthesis, but was blocked by inhibiting postsynaptic G-protein activity, suggesting a postsynaptic nongenomic steroid signaling mechanism that stimulates the release of a retrograde messenger. The rapid glucocorticoid-induced suppression of inhibition was prevented by blocking CB1 receptors and 2-arachidonoylglycerol (2-AG) synthesis, and it was mimicked and occluded by CB1 receptor agonists, indicating it was mediated by the retrograde release of the endocannabinoid 2-AG. The rapid glucocorticoid effect in BLA neurons in vitro was occluded by prior in vivo acute stress-induced, or prior in vitro glucocorticoid-induced, release of endocannabinoid. Acute stress also caused an increase in anxiety-like behavior that was attenuated by blocking CB1 receptor activation and inhibiting 2-AG synthesis in the BLA. Together, these findings suggest that acute stress causes a long-lasting suppression of synaptic inhibition in BLA neurons via a membrane glucocorticoid receptor-induced release of 2-AG at GABA synapses, which contributes to stress-induced anxiogenesis. SIGNIFICANCE STATEMENT: We provide a cellular mechanism in the basolateral amygdala (BLA) for the rapid stress regulation of anxiogenesis in rats. We demonstrate a nongenomic glucocorticoid induction of long-lasting suppression of synaptic inhibition that is mediated by retrograde endocannabinoid release at GABA synapses. The rapid glucocorticoid-induced endocannabinoid suppression of synaptic inhibition is initiated by a membrane-associated glucocorticoid receptor in BLA principal neurons. We show that acute stress increases anxiety-like behavior via an endocannabinoid-dependent mechanism centered in the BLA. The stress-induced endocannabinoid modulation of synaptic transmission in the BLA contributes, therefore, to the stress regulation of anxiety, and may play a role in anxiety disorders of the amygdala.

Indexed as

AnimalsAntiemeticsAnxietyArachidonic AcidsBasolateral Nuclear ComplexBenzoxazinesCalcium Channel BlockersCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsDexamethasoneDisease Models, AnimalEndocannabinoidsEnzyme InhibitorsGlucocorticoidsGlyceridesInhibitory Postsynaptic Potentials(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneAntiemeticsArachidonic AcidsBenzoxazinesCalcium Channel BlockersCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsDexamethasoneEndocannabinoidsEnzyme InhibitorsGlucocorticoidsGlyceridesglyceryl 2-arachidonateMorpholinesNaphthalenesPiperidinesPyrazolesRimonabantamygdalacannabinoidCB1corticosteroidGABAglucocorticoidLTD

Identifiers

PMID27511017
PMCPMC4978804
OpenAlexW2497860062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.